✦ LIBER ✦

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

✍ Scribed by Olle Olerup; Rolf Olsson; Rolf Hultcrantz; Ulrika Broome

Book ID: 118881957
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 920 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)90463-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary sclerosing cholangitis associate

Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease?

✍ Paul J Gow; Kenneth A Fleming; Roger W Chapman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Combined HLA-DR and -DQ disparity is ass

Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis

✍ Evangelos Cholongitas; George V. Papatheodoridis; Paola Zappoli; Athanasios Gian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Combined disparity of human leukocyte antigen (HLA)-DR and -DQ between mother and fetus is associated with less severe ulcerative colitis (UC) during pregnancy. We evaluated whether donor-recipient HLA disparity after liver transplantation (LT) affects UC in patients with primary sclerosing cholangi

HLA-DR3, DQ2 homozygosity in two patient

HLA-DR3, DQ2 homozygosity in two patients with insulin-dependent diabetes mellitus superimposed with ulcerative colitis and primary sclerosing cholangitis

✍ S.-A. IVARSSON; S. ERIKSSON; I. KOCKUM; Å. LERNMARK; S. LINDGREN; K. O. NILSSON; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB